AstraZeneca may sell some of its medicines directly to patients in the US, according to Chief Executive Officer Pascal Soriot. AstraZeneca is looking to the US for growth, with Soriot saying the company will be self-sufficient in the US in a couple of months. He speaks with Bloomberg's Carol Massar, Tim Stenovec, and Madison Muller

Texas Department of Agriculture Commissioner Sid Miller Talks Beef Industry
08:30

CFRA Research's Angelo Zino Talks Nvidia's Revenue Outlook
07:45

Qantas Airways CEO Vanessa Hudson Talks Revamping Fleet & New Routes
10:33